Search research articles
Contact Us
Filters
Showing results (21-30 of 494) with videos related to
Page
of 50
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 3, 2020
What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?
Andrew J Muir
Clinical Therapeutics
|
July 20, 2015
Understanding the Complexities of Cirrhosis
Andrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 12, 2019
Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis?
Andrew J Muir
Expert Review of Anti-Infective Therapy
|
November 26, 2011
Telaprevir for the treatment of chronic hepatitis C infection
Andrew J Muir
Journal of Clinical Gastroenterology
|
January 19, 2013
IL28B in the era of direct-acting antivirals for hepatitis C
Andrew J Muir
Seminars in Gastrointestinal Disease
|
May 10, 2000
The natural history of hepatitis C viral infection
A J Muir
Nature Clinical Practice. Gastroenterology & Hepatology
|
December 6, 2005
HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?
Andrew J Muir
Topics in Antiviral Medicine
|
November 15, 2014
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C care
Andrew J Muir
Health Visitor
|
December 1, 1983
Which three year olds need speech therapy? Uses of the Levett-Muir language screening test
L Levett, J Muir
Lancet (London, England)
|
December 14, 2001
Imatinib for chronic myeloid leukaemia: a NICE mess
D Lim, J Muir
Page
of 50
Search research articles
Search
Showing results (21-30 of 494) with videos related to
Sort By:
Page
of 50
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 3, 2020
What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?
Andrew J Muir
Clinical Therapeutics
|
July 20, 2015
Understanding the Complexities of Cirrhosis
Andrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 12, 2019
Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis?
Andrew J Muir
Expert Review of Anti-Infective Therapy
|
November 26, 2011
Telaprevir for the treatment of chronic hepatitis C infection
Andrew J Muir
Journal of Clinical Gastroenterology
|
January 19, 2013
IL28B in the era of direct-acting antivirals for hepatitis C
Andrew J Muir
Seminars in Gastrointestinal Disease
|
May 10, 2000
The natural history of hepatitis C viral infection
A J Muir
Nature Clinical Practice. Gastroenterology & Hepatology
|
December 6, 2005
HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?
Andrew J Muir
Topics in Antiviral Medicine
|
November 15, 2014
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C care
Andrew J Muir
Health Visitor
|
December 1, 1983
Which three year olds need speech therapy? Uses of the Levett-Muir language screening test
L Levett, J Muir
Lancet (London, England)
|
December 14, 2001
Imatinib for chronic myeloid leukaemia: a NICE mess
D Lim, J Muir
Page
of 50